| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.084 | 13.387 | 15.914 | 14.791 | 12.181 | 10.621 | 9.597 | 8.471 | 9.436 | 5.784 |
| Total Income - EUR | 13.084 | 13.387 | 15.924 | 14.791 | 12.181 | 10.621 | 9.597 | 8.471 | 9.436 | 5.804 |
| Total Expenses - EUR | 4.882 | 3.563 | 3.240 | 3.404 | 3.311 | 2.463 | 3.201 | 3.424 | 3.566 | 3.774 |
| Gross Profit/Loss - EUR | 8.202 | 9.825 | 12.684 | 11.387 | 8.870 | 8.158 | 6.396 | 5.048 | 5.870 | 2.030 |
| Net Profit/Loss - EUR | 7.809 | 9.423 | 12.206 | 10.944 | 8.504 | 7.851 | 6.149 | 5.029 | 4.931 | 1.712 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sensimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 605 | 198 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 236 | 1.314 | 9.023 | 17.646 | 8.651 | 8.005 | 17.703 | 8.458 | 5.238 | 2.067 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 312 | 0 | 0 | 0 | 625 | 4.043 | 3.076 | 3.796 | 0 |
| Cash | 236 | 1.003 | 9.023 | 17.646 | 8.651 | 7.379 | 13.660 | 5.383 | 1.442 | 2.067 |
| Shareholders Funds | -12.892 | -3.331 | 8.932 | 17.532 | 8.555 | 7.900 | 6.197 | 5.078 | 4.979 | 1.760 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.733 | 4.843 | 91 | 114 | 96 | 105 | 11.506 | 3.381 | 259 | 307 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sensimed S.r.l.